Avricore Health (AVCRF) Short term Debt (2013 - 2023)

Avricore Health has disclosed Short term Debt across 5 years of filings, most recently posting $29381.4 for Q4 2023.

• In Q4 2023, Short term Debt changed 0.29% year-over-year to $29381.4; the TTM figure through Dec 2023 stood at $29381.4 (changed 0.29% YoY), while the FY2023 annual figure was $29646.7, down 3.64% from the prior year.
• Short term Debt eased to $29381.4 in Q4 2023, from $29837.2 in the prior quarter.
• Over the last five years, Short term Debt for AVCRF reached as high as $768252.8 in Q4 2020 and fell as low as $29381.4 in Q4 2023.
• The 4-year median for Short term Debt is $31591.5 (2022), against an average of $195352.4.
• Annual changes were most pronounced in 2021 — Short term Debt plunged 95.87% — and 2022, when it retreated 0.08%.
• A 4-year view of Short term Debt shows it stood at $768252.8 in 2020, then sank by 95.87% to $31733.4 in 2021, then declined by 7.14% to $29468.1 in 2022, then declined by 0.29% to $29381.4 in 2023.
• According to Business Quant data, Short term Debt over the past three periods registered $29381.4, $29837.2, and $29778.1 for Q4 2023, Q3 2023, and Q2 2023 respectively.